Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

p-BNC, The Programmable Bio-Nano-Chip: Nokia Sensing XCHALLENGE Finalist



  p-BNC, The Programmable Bio-Nano-Chip: Nokia Sensing XCHALLENGE Finalist

Business Wire

HOUSTON -- October 31, 2013

The McDevitt Research Group, a medical micro device group committed to
improving the speed, accuracy and affordability of global disease diagnosis,
announces the p-BNC, the Programmable Bio-Nano-Chip system. Currently under
development, p-BNC is a credit card sized disposable device that is envisioned
to work in conjunction with a toaster sized imaging platform that would
analyze biomarkers found in bodily fluids and relay complex test results to
consumers through an intuitive smart phone interface.

The p-BNC Team Photo: From left to right: Michael McRae, Glennon Simmons,
Ahmed Haque and John T. Mc ...

The p-BNC Team Photo: From left to right: Michael McRae, Glennon Simmons,
Ahmed Haque and John T. McDevitt. (Photo: Business Wire)

A 2013 Nokia Sensing XCHALLENGE finalist, the programmable bio-nano-chip
technology has the potential to change the practice of medicine by
incorporating key advances in software, electronics and communication sectors.
The p-BNC technology serves as the marriage of in-vitro diagnostics and
electronics and is the result of a public-private partnership with CPRIT^1;
the Rice university based McDevitt Research Group, Mobisoft, a global leader
in App development; Porex Corporation, the global leader in advanced porous
materials and MiniFAB Corporation, a global leading contract engineering firm
providing custom development and manufacture of disposable polymer
micro-engineered products. Additionally, Dr. McDevitt’s research in cardiac
heart disease and oral cancer is in part supported by grants from the NIH’s
National Institute of Dental and Craniofacial Research.

The in development p-BNC point of care analysis solution will use a common
high performance image-based analyzer platform for all major types of
diagnostics for the likes of acute myocardial infarction, congestive heart
failure, cardiac risk assessment, diabetes and chemical additions. The p-BNC
lab card is currently being evaluated by six major clinical trials, the p-BNC
system has the potential to diagnose in minutes what previously took labs,
hours or days. The p-BNC synergizes components and achievements from
nanotechnology, molecular diagnosis, microfluidics and microelectronics to
create a new and powerful measurement tool in a small device footprint.

About McDevitt Research Group:

The McDevitt Lab is a Houston-based medical micro device group committed to
improving the speed, accuracy and affordability of disease diagnosis on a
global basis. Leveraging strong foundations in nano-science and
bioengineering, micro fabrication techniques, microfluidics, biosensors,
clinical chemistry and artificial intelligence, the McDevitt laboratory, over
the past 15 years has not only pioneered development of the p-BNC sensor
platform, but also begun to use this powerful information gathering tool to
gain molecular level insights into disease progression. These mini-detection
ensembles with multiplexed and multi-class (cellular, genomic, proteomic)
capabilities are now being customized for cancer diagnostics, cardiovascular
disease, saliva-based diagnostics, infectious diseases, drugs of abuse
detection, and cell imaging systems.

To learn more about p-BNC, visit the McDevitt lab at http://mcdevitt.rice.edu

^1Cancer Prevention & Research Institute of Texas

For investigational use only. Not currently for sale.

The Future of Diagnostics is in Your Hands.

Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20131031006171/en/

Multimedia
Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50741441&lang=en

Contact:

McDevitt Research Group
John T. McDevitt, Ph.D., 713-348-2123
Brown-Weiss Professor of Bioengineering & Chemistry
Departments of Bioengineering & Chemistry
Rice University, Houston, TX
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement